IARC News
IARC Seminars: Using decision science methods to optimize cervical cancer prevention policies
20/04/2018
Title: Using decision science methods to optimize cervical cancer prevention policies
Speaker: Dr Jane J. Kim
Professor of Health Decision Science, Harvard T.H. Chan School of Public Health, Boston MA, USA
Watch video
IARC Monographs evaluation of the carcinogenicity of quinoline, styrene, and styrene-7,8-oxide
19/04/2018
The results of the recent IARC Monographs evaluation of the carcinogenicity of quinoline, styrene, and styrene-7,8-oxide have now been published in The Lancet Oncology. This summary article presents the conclusions of the IARC Monographs Meeting 121. The new evaluations of styrene and styrene-7,8-oxide update the previous evaluations by the IARC Monographs in 2002 and 1994, respectively. This is the first time an IARC Monographs Working Group has considered quinoline.
The full scientific assessment will be published as Volume 121 of the IARC Monographs.
IARC Monographs Vol. 121 Group
Lancet Oncol, Published online 18 April 2018 ;
http://dx.doi.org/10.1016/S1470-2045(18)30316-4
Read more
IARC signs comprehensive Memorandum of Understanding with the University of Otago, New Zealand
18/04/2018 The International Agency for Research on Cancer (IARC) is pleased to announce the signature of a new Memorandum of Understanding (MoU) with the University of Otago, New Zealand. The MoU focuses on building capacity and specific research collaborations that will strengthen the evidence-base for cancer prevention and control. The areas of focus include cooperation on the development of cancer registration infrastructure in the Pacific region, research studies in the domains of cancer surveillance, aetiology and prevention, as well as exchange programmes supporting the education and training of early-career and senior scientists. Read more
IARC Postdoctoral Opportunities - Section/Group: Section of Genetics/Genetic Epidemiology Group
13/04/2018 A postdoctoral opportunity in Bioinformatics / Computational biology is immediately available within the Genetic Epidemiology Group to contribute to our multidisciplinary cancer studies which integrate epidemiology and genome-wide investigations (large-scale GWAS, exome/genome/transcriptome sequencing) together with medical history and clinical outcome of cancer patients from all over the world. Read more
Press Releases
Publications
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
07/09/2017
The WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues is a Revised 4th Edition Volume of the WHO series on histological and genetic typing of human tumours. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies monitoring response to therapy and clinical outcome.
This classification, prepared by 132 authors from 23 countries, contains about 1300 colour images and tables, and more than 4500 references.
Read more
